Trial intelligence / Profile preview

Pharmacokinetics and Safety of Radiprodil With Carbamazepine or Itraconazole in Healthy Adults

NCT07884734Phase 1Active, not recruiting

Sponsor
GRIN Therapeutics, Inc.
Start
Jun 2026
Primary completion
Oct 2026
Countries
1
01

Overview

Phase 1, open-label trial of radiprodil (2 arms), sponsored by GRIN Therapeutics, Inc. Primary endpoints: Area Under the Plasma Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration, Area Under the Plasma Concentration-Time Curve From Time Zero Extrapolated to Infinity and 1 more. Started Jun 2026; status: active, not recruiting.

02

Drugs

radiprodil

Beyond the preview

Go deeper on NCT07884734.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07884734.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call